StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Mirati Therapeutics (MRTX) Trades at High, Up 150%
September 15, 2017 10:54 AM
Mirati Therapeutics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Momentum Movers
Next Articles
Mirati Therapeutics (MRTX) PT Raised to $9 at Leerink Partners
September 15, 2017 8:04 AM
Mirati Therapeutics (MRTX) Reports Positive Preliminary Data From On-Going Clinical Trials of Sitravatinib in Non-Small Cell Lung Cancer
September 14, 2017 4:34 PM
Mirati Therapeutics Presents Positive Preliminary Data From On-Going Clinical Trials Of Sitravatinib In Non-Small Cell Lung Cancer
September 14, 2017 4:33 PM
Mirati Therapeutics (MRTX) Halted, News Pending
September 14, 2017 4:27 PM
